08158.HK
China Regenerative Medicine International Limited
HKSE · Healthcare · Biotechnology · HK
HKD 0.18
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 1.83x
- PEG TTM
- 0.02x
- Price / book
- 0.97x
- Price / sales
- 0.51x
- Price / cash flow
- 3.51x
Enterprise value
- Enterprise value
- HKD 91.2M
- EV / sales
- 0.85x
- EV / EBITDA
- 3.86x
- EV / EBIT
- 9.45x
- Market cap
- HKD 54.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026